LONDON – Final results of the community pilot in Liverpool, U.K., that used the controversial Innova Medical Group Inc. lateral flow device to test all comers for COVID-19, show new cases fell by 21% ...
PASADENA, Calif. and CAERPHILLY, South Wales, May 26, 2021 /PRNewswire/ -- Innova Medical Group, the world's largest provider of rapid antigen tests, has announced an initial investment in South Wales ...
The proportion of people with current covid-19 infection missed by the Innova lateral flow test (LFT) is substantial enough to be of clinical importance, particularly when testing people without ...
UK government plans to widen the roll out of the Innova lateral flow test without supporting evidence risks serious harm, warn experts in The BMJ today. More than £1 billion have been spent on ...
Food and Drug Administration last week requested that Innova Medical Group stop sales of its COVID antigen rapid qualitative test and warned the public against using the test, citing concerns about ...
University of Birmingham (U.K.) signs licensing deal with Innova Medical Group – the world's largest COVID-19 at-home self-test provider - to Commercialize New Proven Testing Method in the Global ...
The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds ...
SYGNIS AG, under the Innova Biosciences (Innova) brand name, a specialist provider of bioconjugation products and services, today announced it has established a partnership with Abingdon Health Ltd ...
During the early stages of the coronavirus disease 2019 (COVID-19), rapid testing was imperative for public health policymakers and health care workers in order to determine where and what measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback